Publications by authors named "Maria Domenica Guglielmi"

Article Synopsis
  • Amyloidosis is a systemic disease caused by the buildup of low molecular weight proteins in the body's tissues, adversely affecting various organs, particularly the heart.
  • Cardiac amyloidosis (CA) is linked to poor outcomes, with the majority being light chain amyloidosis (AL-CA) and transthyretin amyloidosis (ATTR), which can further be classified into wild type (ATTRwt) and hereditary (ATTRh-CA).
  • Early diagnosis of CA, especially regarding atrial involvement, is crucial for effective treatment, as new diagnostic techniques like advanced echocardiography and cardiac MRI can improve patient prognosis and survival rates significantly.
View Article and Find Full Text PDF

Background: In patients with suspected deep vein thrombosis (DVT), D-dimer thresholds adjusted to age or clinical pretest probability (CPTP) increase the proportion of patients in whom DVT can be safely excluded compared to a standard approach using a fixed D-dimer threshold. Performance of these diagnostic strategies among cancer patients is uncertain.

Aim: To compare the performance of age- and CPTP-adjusted D-dimer approaches among cancer outpatients with clinically suspected DVT, and derive a cancer-specific CPTP rule.

View Article and Find Full Text PDF

Background: Limited prospective data exist about the clinical relevance of frailty in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) receiving direct oral anticoagulants (DOACs). The aim of this study was to evaluate whether frailty phenotype identifies DOAC-treated patients at higher risk of adverse clinical outcomes.

Methods: Consecutive, adult outpatients treated with DOACs for AF or VTE were prospectively enrolled.

View Article and Find Full Text PDF

The long-term performance of prediction scores for venous thromboembolism (VTE) in cancer patients has been poorly investigated. We evaluated the discriminatory performance of the Khorana, PROTECHT, CONKO, and ONKOTEV scores for the first 3-6 months and for 12 months, and re-assessed scores after 3-6 months to determine the influence of variations in patients' risk classification on performance. Retrospective cohort of ambulatory patients with active cancer who were scheduled to receive first or new line of chemotherapy.

View Article and Find Full Text PDF

Introduction: The effects of multiple inherited and acquired thrombophilic defects on the outcome of in-vitro fertilization (IVF) remain unexplored. The aim of this study was to evaluate the association between multiple thrombophilia and clinical outcomes in a large prospective cohort of women undergoing IVF.

Materials And Methods: Consecutive women scheduled for IVF were eligible.

View Article and Find Full Text PDF

Background: Although well-established for suspected lower limb deep venous thrombosis, an algorithm combining a clinical decision score, d-dimer testing, and ultrasonography has not been evaluated for suspected upper extremity deep venous thrombosis (UEDVT).

Objective: To assess the safety and feasibility of a new diagnostic algorithm in patients with clinically suspected UEDVT.

Design: Diagnostic management study.

View Article and Find Full Text PDF

Toll-like receptor-4 (TLR-4) gene polymorphisms have been associated with a lower risk of atherosclerosis. High levels of soluble P-selectin (sP-selectin) and von Willebrand factor predict an increased risk for cardiovascular events and correlate to atherosclerotic risk factors. The relationship between these markers and TLR-4 gene polymorphisms was evaluated in a cohort of consecutive hypercholesterolemic outpatients.

View Article and Find Full Text PDF

Recently, leptin has been suggested as a possible cause of atherosclerotic disease. In the present study, we have investigated in postmenopausal women (n = 60; age: 52 +/- 13) the relationship between circulating levels of leptin, oxidized LDL (Ox-LDL) and other biochemical and anthropometric variables of atherosclerotic risk. In addition, we have evaluated soluble thrombomodulin (sTM) as a marker of endothelial damage.

View Article and Find Full Text PDF